| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.16 | 0.0005 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0009 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.15 | 0.001 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.36 | 0.005 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.094 | 0.005 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.13 | 0.007 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.01 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.079 | 0.01 |